|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 3 May 2006
doi: 10.1242/dev.02377
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,
UMR CNRS 7000, Cytosquelette et Développement, Faculté de Médecine Pitié-Salpêtrière, 105 boulevard de l'Hôpital, 75013 Paris, France and Université Pierre et Marie Curie, Paris 6, France.
Author for correspondence (e-mail:
nardelli{at}ext.jussieu.fr)
Accepted 27 March 2006
| SUMMARY |
|---|
|
|
|---|
Key words: GATA2, Cell cycle, Neuronal progenitors, Posterior neural tube, Mouse, Chick
| INTRODUCTION |
|---|
|
|
|---|
Regulatory proteins involved in neuron specification have also been shown
to influence the cell cycle (Dubreuil et
al., 2000
; Edlund and Jessell,
1999
; Tanabe et al.,
1998
). However, data concerning the genetic events, which most
probably link specification, modulation of Notch signalling, pro-neural gene
trans-activation and the cell cycle machinery, are still limited. Pax6 has
been shown to regulate the expression of neurogenin 2 (Ngn2;
Neurog2 Mouse Genome Informatics) in several populations of
neuronal precursors in both the brain and the spinal cord
(Scardigli et al., 2003
),
whereas Mash1 has been placed upstream of genetic cascades leading to
the differentiation of serotoninergic
(Pattyn et al., 2004
) and
sympathetic (Tsarovina et al.,
2004
) neurons. In the retina, cyclin D1 and cell cycle inhibitors,
such as the p57/Kip2 (Cdkn1c Mouse Genome Informatics) and p27/Kip1
(Cdkn1b Mouse Genome Informatics) proteins, have been shown to be
differentially involved in distinct differentiation pathways, suggesting that
the expression of cell cycle regulators may be dependent on specification
genes (Dyer and Cepko, 2001
;
Livesey and Cepko, 2001
).
Deciphering crosstalk between specification genes, proneural genes and the
machinery of the cell cycle appears therefore to be a key issue.
Here, we report several lines of data supporting the involvement of GATA2,
a transcription factor that contains two C4 zinc fingers, in such crosstalk.
GATA2 was first described as a regulatory protein that plays a major role in
the proliferation of progenitors and in lineage specification during early
hematopoiesis. Indeed Gata2 loss of function in the mouse leads to
the death of embryos between E9.5 and E11, owing to severe defects in primary
hematopoiesis (Tsai et al., 1994). Gata2 also appears to be
indispensable for the differentiation of several other tissues during
embryogenesis, including the uro-genital
(Zhou et al., 1998
) and the
nervous systems. In the latter case, Gata2 is known to participate in
the differentiation pathway of different types of neurons in the ventral
hindbrain and spinal cord, namely cranial nerves
(Nardelli et al., 1999
;
Pata et al., 1999
),
serotoninergic neurons (Craven et al.,
2004
; Pattyn et al.,
2004
) and V2 interneurons
(Karunaratne et al., 2002
;
Zhou et al., 2000
). The fact
that, in each of these lineages, Gata2 activation is turned on in
early precursors raised the possibility that Gata2 may influence the
cell cycle and probably, like other specification genes, participate in its
withdrawal. In order to gain further insight into this possible new aspect of
Gata2 function, we carried out analyses aimed at a better
understanding of how Gata2 is linked to the cell cycle. Our data have
established that Gata2 expression is sufficient to force cycling
neural progenitors to switch to a quiescent and eventually differentiating
state in vivo. In addition, we show that Gata2 acts as a potent
inhibitor of proliferation in embryonic undifferentiated neuroepithelial cells
in culture. Such negative control on the proliferation of neuronal progenitors
appears to be exerted by Gata2 by interfering with the regulation of
cell cycle components and by shutting off the Notch pathway.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Electroporation of chick embryos in ovo
In order to obtain the PAdRSV-GATA2HA expression plasmid, the entire human
sequence encoding Gata2 was amplified by PCR so as to introduce a
NcoI site at the 5' end, one copy of the HA epitope and an
EcoRV site at the 3' end of the cDNA. The PCR product was
cloned into PGEM3, entirely checked by sequencing and transferred into
pAdRSV-SP (Giudicelli et al.,
2001
) by NcoI and EcoRV digestions. The
pCAGGS-cId2 (Dubreuil et al.,
2000
), pAdRSV-bGal (Giudicelli
et al., 2001
) and pAdRSVGFP plasmids were kindly provided by
Christo Goridis, Pascale Gilardi and Philippe Ravassard, respectively.
Fertilised eggs from Gallus gallus domesticus hens were incubated at
38°C in a humidified oven. The DNA solution (2-3 mg/ml) was injected in
the hindbrain and the spinal cord with an Eppendorf Femtojet injector at stage
HH12 or HH15. Six pulses of 25 V for 50 mseconds each were then applied with a
BTX ECM 830 electroporator. Embryos were further incubated for either 24 or 48
hours (occasionally for 6-12 hours) before being fixed as described below. For
BrdU incorporation, a single injection of a 20 mg/ml BrdU solution was
injected into the heart or the umbilical vein 30 minutes prior to collecting
the embryos.
Immunohistology and in situ hybridisation
Embryos, fixed in paraformaldehyde (PFA) 4% for 2-3 hours for
immunostaining and overnight for in situ hybridisation, were equilibrated in
PBS 30% sucrose, embedded in PBS containing 15% sucrose and 7% gelatin and
frozen at 50°C. Serial sections (12 µm) were then cut with a
LEICA CM 3000 cryostat.
For immunostaining, sections were saturated with PBS/0.1% Triton/10% foetal calf serum (FCS) (saturation solution) for 30 minutes and incubated with the primary antibody diluted in the same solution. After several washes in PBS/0.1% Triton, the secondary antibody, diluted in the saturation solution, was added for 30 minutes at room temperature. Slides were then mounted in Fluorescent mounting medium (DAKO). Black and white pictures were obtained with a TCS Leica confocal microscope and false-coloured in Photoshop (Adobe).
BrdU staining was performed as described
(Ravassard et al., 1997
),
except that the secondary antibody was coupled to Alexa Fluor 488 or 546. The
nuclei were stained with DAPI before mounting. To assess the percentage of
Gata2-expressing cells being in S phase in E10.5 mouse embryos,
BrdU-positive cells were counted among 850 Gata2-positive cells,
distributed into 10 spinal cord sections from two different E10.5 embryos. In
chick embryos misexpressing GATA2-HA, all the nuclei and the BrdU-positive
nuclei were counted on the electroporated and the control sides on at least
four sections in three different embryos. Counting was carried out using
Metamorph software. The same approach was applied to calculate the percentage
of phospho-Histone3-positive cells.
TUNEL stainings were performed with the Apodetectplus kit (Qbiogen) following the supplier's instructions.
In situ hybridisation on sections were performed according to Ravassard et
al. (Ravassard et al., 1997
).
For further immunostaining, sections were processed as described earlier.
Staining was analysed with a BX60 Olympus epifluorescence microscope, and
pictures were taken with a black and white Cool Snap camera (Ropper
Scientific) and false-coloured in Photoshop (Adobe).
Primary and secondary antibodies
The following primary antibodies were used: mouse monoclonal anti-p27/Kip1
(BD Bioscience, 1/2000), anti-ßIII-Tubulin (Babco, 1/10,000), anti-BrdU
(DAKO, 1/1000), anti-Isl1 (DSHB; 1/20), 3A10 anti-neurofilament-associated
protein (1/500; DSHB), anti-NeuN (Chemicon, 1/1000), rat monoclonal anti-HA
epitope (Roche, 1/2000), rabbit polyclonal anti-phosho-Histone3 (Upstate
Biotechnology, 1/1000), anti-p57/Kip2 (BD Bioscience, 1/2000), anti-GATA2
(Santa-Cruz, 1/400), anti-GFP (Abcam, 1/1000) and anti-Sox2 (Abcam, 1/1000).
The fluorescent secondary antibodies, goat anti-mouse, -rabbit and -rat IgG,
all highly absorbed against other species and coupled either to Alexa Fluor
488 or 546 (Molecular Probes) were diluted 1/2000.
In situ probes
The mouse probes were: Gata2
(Nardelli et al., 1999
);
cyclin D1, cyclin D2 and cyclin D3 (Wianny
et al., 1998
); full-length p27 cDNA
(Toyoshima and Hunter, 1994
);
700 bp AccI/XbaI fragment for Sox2; rat
Notch1 (Lindsell et al.,
1996
); Dll1 (Campos et
al., 2001
); and Jag1, full-length Hes5 cDNA,
Mash1 and Ngn2 (Gradwohl
et al., 1996
). The chick probes were: full-length cDNA for
Gata2; Sox2, Dll1 and Jag1 (obtained from Nicole Le
Douarin's laboratory); Ngn2
(Novitch et al., 2001
);
Cash1 (Groves et al.,
1995
); and cyclin D1 (Lobjois
et al., 2004
). The full chick Hes5-coding sequence was
cloned by RT-PCR from E6.5 chick retina total RNA, using the following
primers: 5'-GCGGCTCGAGAGCCAGCTTCGTGC-3' (forward) and
5'-CCTCTGGAATGTGCACCAGTGTCC-3' (reverse). The cDNA was checked by
sequencing. To monitor the activation of cyclin D1 and Cash1,
antisense probes devoid of bacterial sequence were synthesised from cDNA
fragments amplified by PCR. Primers for cyclin D1 amplification were as
described (Lobjois et al.,
2004
); Cash1 primers were
5'-TGATGCGCTGCAAGAGGCGG-3' (forward) and
5'-GTAATACGACTCACTATAGCACCGGGAAACGTGGTCCAGA-3' (reverse).
Likewise, the chick Id2 probe was synthesised by PCR amplification of
the cDNA included in pCAGGS-cId2, using the following primers:
5'-AAGCTTTCAGCCCCGTGCGGT-3' (F) and
5'-GTTAATACGACTCACTATAGAGCGTGGATTCCTCCCCTCC-3' (R).
Cell culture
Mouse embryonic neuroepithelial cell cultures (ENC) were initiated from
neural tube explants of E9.5 wild-type and
Gata2/ embryos, generated in the same
genetic background and maintained as described
(Nardelli et al., 2003
). All
comparative experiments between wild-type and
Gata2/ cells were performed at matching
numbers of passages, which never exceeded 12. To compare the proliferation
rate by BrdU incorporation, cells were seeded on glass cover-slips in 24-well
plates. At 50% confluency, the cells were placed in medium containing 0.5%
FCS. Twenty-four hours later, BrdU (10 µg/ml of culture medium) was added
with 10% FCS. The cells were then fixed at different time intervals and
treated as previously described for tissue sections. The nuclei were stained
with DAPI before the slides were mounted with Dako Fluorescence Mounting
Medium. Experiments for each time point were carried out in duplicate, and all
experiments were repeated three times. Nuclei were then counted using
Metamorph software. Counting was carried out on at least five fields,
including more than 200 cells selected on different coverslips. Transfection
experiments and immunostaining were performed as described
(Nardelli et al., 2003
).
During GATA2-HA transient expression experiments, BrdU incorporation in
transfected and control cells was started 30 hours after transfection and
allowed for 15 hours. In situ hybridisation on transfected cells was performed
as described (Nardelli et al.,
2003
). As this protocol does not permit further immunostaining,
pAdRSV-ßGal plasmid was added to pAdRSV-GATA2HA to detect transfected
cells by X-Gal coloration before in situ hybridisation
(Nardelli et al., 2003
).
Control cells were transfected with pAdRSV-ßGal alone. The culture medium
was changed 6 hours after transfection, replaced by fresh medium and collected
24 hours later. This conditioned medium was diluted twice with fresh medium
and applied for 24 hours on Gata2/ cells,
plated on glass cover-slips in 24-well plates. NB2a neuroblastoma cells were
cultured in DMEM supplemented with 10% serum and processed as ENC for
immunostaining, transfection and BrdU incorporation.
Semi-quantitative and quantitative PCR reactions
Total RNA from wild type or Gata2/
embryonic neuroepithelial cells was prepared by adding TRIZOL (Invitrogen)
directly onto the cells in the tissue-dish and following the manufacturer's
instructions for extraction. RNA was further purified on RNeasy columns
(QIAGEN), treated with DNAse, then checked and quantified on Agilent chips.
Experiments were repeated twice on three different RNA preparations.
Quantitative RT-PCR was performed using a SIGMA SYBR Green Quantitative RT-PCR
kit.
Reverse-transcription was performed from 5 µg RNA, with Superscript III (Invitrogen). Semi-quantitative PCR was performed with 0.5 µl of reverse-transcription reaction, using FastStart Taq polymerase (Roche). The PCR program included an initial denaturation step of 95°C for 4 minutes, then 45 seconds at 95°C, 45 seconds at 65°C and 30 seconds at 72°C for actin and cyclin D2 (20 cycles), cyclin D1 and Notch1 (23 cycles), cyclin D3 and p27 (27 cycles), and for cyclin E1 (30 cycles). The PCR products, all sized between 300 and 350 bp, were separated in BEt-agarose gels and then analysed with Gel-Doc camera and soft-ware (BioRad) to calculate the relative amount of each product.
The quantitative PCR reactions (20 µl) were performed in a MX 4000 apparatus (Stratagene). The program was as follows: an initial step at 95°C for 10 minutes; 30 seconds at 95°C, 1 minute at 65°C and 30 seconds at 72°C for 36 cycles; then 95°C for 1 minute and a 1°C increment/minute from 55°C up to 95°C to generate denaturation curves.
The primer sequences were as follows: cyclin D1, 5'-TGTGGCCCTCTGTGCCACAG-3' (forward) and 5'-TCTCGCACGTCGGTGGGCGT3 (reverse); cyclin E1, 5'-TCAGGAGCAGCAGGGGTCTGC-3' (forward) and 5'-CTGTGGGCTCTGCATCCCACA-3' (reverse); p27, 5'-TGGAGAGGGGCAGCTTGCCC-3' (forward) and 5'-AGGCCGGGCTTCTTGGGCGT-3' (reverse); cyclin D2, 5'-TGGCCGCAGTCAGGGCTCACG-3' (forward) and 5'-TCAGGGCATCACACGTGAGTGTGT-3' (reverse); cyclin D3, 5'-CCTGGCCTTGATTCTGCACCG-3' (forward) and 5'-GCTTCCCTGAGGCTCTCCCTG-3' (reverse); actin, 5'-GTGGGCCGCTCTAGGCACCAA-3' (forward) and 5'-CTCTTTGATGTCACGCACGATTTC-3' (reverse); Notch1, 5'-CAGTCGTCCGACTGGGGACA-3' (forward) and 5'-TCGTCCGTGTGAGCACCCAC-3' (reverse).
| RESULTS |
|---|
|
|
|---|
Gata2 is sufficient to arrest the proliferation of neuronal progenitors in vivo
To assess the possible role of Gata2 in the withdrawal of neuronal
progenitors from the cell cycle, we first induced Gata2 misexpression
in the neural tube of chick embryos by electroporation of pAdRSV-GATA2HA, a
plasmid that drives ubiquitous expression of the human GATA2 protein tagged
with the HA epitope. Compared with the non-electroporated side of the neural
tube, GATA2-HA expression caused a marked decrease (5% versus 11%) in cells
containing phospho-Histone3, a pan-marker of the M phase
(Fig. 1G-I,M). Likewise, short
pulses of BrdU incorporation, performed for half an hour before collecting the
embryos, demonstrated a significant decrease in BrdU-positive cells on the
electroporated side (28% compared to 47%) and a very limited coincidence with
GATA2-overexpressing cells (Fig.
1J-L,N). In addition, we observed that GATA2-HA caused a marked
downregulation of Sox2, a pan-marker of the neural progenitor stage
(Fig. 1O,P). These results were
consistent with the hypothesis that GATA2 can behave as an inhibitor of the
cell cycle and may thus actively participate in the switch to the post-mitotic
stage in neural progenitors.
Interaction between Gata2 and the cell cycle machinery
To confirm such a role, we investigated possible interactions between
Gata2 and the cell cycle. In most cases, cells leave the cell cycle
in G1, when the concentration of cell cycle inhibitors has increased
sufficiently to prevent them from reaching the restriction point, thus forcing
them to take the G0 branch. These inhibitors principally impair the activity
of cyclin-dependent kinases, such as CDK4 and CDK6, which is dependent on
interaction with D-type cyclins, namely cyclin D1, D2 and D3
(Cunningham and Roussel, 2001
;
Murray, 2004
). However, in
addition to their active role during the progression towards the G1/S
transition, D-cyclins have also been reported, at high expression levels, to
exert the opposite effect and to sustain the maintenance of quiescence
(Meyyappan et al., 1998
;
Pagano et al., 1994
).
Speculating that Gata2 could probably affect D-cyclin expression, we
first closely examined the distribution of their respective transcripts in the
ventral neural tube. At E10.5, surprising distinguishing features were
observed in the expression patterns of cyclin D1 and D2. As shown in
Fig. 2A,B, cyclin D1
transcripts were detected at low levels (cyclin D1low) in the
ventricular zone and not at all in the marginal layer, which contains maturing
neuron precursors. Strikingly, within the ventricular zone, a high level of
expression (cyclin D1high) was observed in a domain which abuts the
dorsal limit of motoneurons (Fig.
2A,E). This domain most probably includes the presumptive domain
of Gata2-expressing V2 interneurons and more dorsal interneurons,
such as V1. Furthermore, the semi-lateral position of the majority of these
cells suggested that this high level of expression was associated with newborn
precursors. At the same stage, cyclin D2, like cyclin D1, showed two levels of
transcription. In contrast to the general low activation observed in the
progenitors, transcripts were conspicuously detected in the marginal layer
along the entire dorsoventral axis, although to a lesser extent at the level
of motoneurons and more ventral precursors
(Fig. 2C). Cyclin D3 expression
was restricted to the ventricular zone
(Fig. 2D). To summarise, the
transcription levels of the three cyclin D genes at E10.5 appeared to vary
individually according not only to the phase of the cell cycle, but also to
cell specificity. In E10.5 Gata2/ embryos,
the transcription pattern of neither cyclin D2 nor cyclin D3 seemed to be
significantly affected (data not shown). By contrast, we observed a decrease
in the number of newborn precursors distinguished by cyclin D1high
transcription (Fig. 2B). This
suggested that Gata2 might participate in the upregulation of cyclin
D1 in newly committed precursors. This hypothesis was further assessed in
Gata2 gain-of-function experiments. Indeed, GATA2-HA misexpression in
the spinal cord of chick embryos drove ectopic activation of cyclin D1
(Fig. 2F-H). Surprisingly, such
a regulation occurred not only in GATA2-HA-expressing cells but also in
neighbouring non-expressing cells (Fig.
2H). Wondering whether this effect was related to the activation
of the endogenous Gata2 gene, we checked its expression in
electroporated embryos. Indeed, as in the case of cyclin D1, we observed a
clear activation of the endogenous Gata2 gene not only in
GATA2-HA-positive cells, but also in the neighbouring negative cells
(Fig. 2J-L). To exclude the
possibility that the lack of GATA2-HA detection was due to its degradation, we
provided evidence that endogenous chick Gata2 activation was induced
in cells that were not stained by the anti-HA antibody 6 and 12 hours after
electroporation (data not shown). In conclusion, GATA2 misexpression led to
activation of the endogenous Gata2 and cyclin D1 genes, and some
aspects of this activation appears to be generated by a non-cell autonomous
process.
|
|
Gata2 control on cell cycle can be uncoupled from neuronal differentiation
We next wanted to know whether such a role was coupled to neuronal
differentiation. Twenty-four hours after electroporation, GATA2-HA
misexpression was found to induce the expression of early markers of neuronal
differentiation, such as ßIII-Tubulin/Tuj1
(Fig. 3D-F) and neurofilament
(Fig. 3G-I), whereas NeuN
expression was not detected (Fig.
3J-L). ßIII-Tubulin/Tuj1 induction appeared to overlap
partially with cyclin D1 activation (see Fig. S1 in the supplementary
material). Further analyses carried out 48 hours after electroporation showed
that some of the GATA2 misexpressing cells had migrated into the marginal
zone. These cells continued to express p27
(Fig. 4A-C),
ßIII-Tubulin/Tuj1 (Fig.
4D-F) and neurofilament (Fig.
4G-I), and had activated NeuN expression
(Fig. 4J-L). At this stage, the
expression of these markers appeared to be exclusive of that of cyclin D1 (see
Fig. S1 in the supplementary material). By contrast, the rest of the GATA2
misexpressing cells had not migrated to the marginal zone, were not dividing
(data not shown) and were not expressing p27/Kip1
(Fig. 4A-C) or neuronal
differentiation markers such as ßIII-Tubulin
(Fig. 4D-F), neurofilament
(Fig. 4G-I) or NeuN
(Fig. 4J-L). GATA2-HA
misexpressing precursors thus appeared either to differentiate normally or to
become blocked in the ventricular zone and probably unable to progress along
the differentiation pathway.
|
Gata2 counteracts Notch signalling
GATA2 capacity to drive cells out of the cell cycle might be achieved
through inhibition of the Notch pathway. We therefore analysed the impact of
Gata2 loss- and gain-of-function on the expression of effectors of
the Notch pathway such as Notch1, Dll1, Hes5, Mash1 and
Ngn2. In this regard, loss-of-function studies did not turn out to be
informative as only slight differences could be observed (data not shown),
probably owing to the low distribution of Gata2-expressing cells at
E10.5. By contrast, gain-of-function studies showed that Gata2
misexpression caused a clear repression of Dll1
(Fig. 5A,B), Ngn2
(Fig. 5D,F), Notch1
(Fig. 5G,H), Hes5
(Fig. 5G,I) and even of
Serrate1/Jag1 (Fig.
5A,C), the expression of which does not overlap that of
Gata2. Only Cash1, the chick Mash1 homologue,
appeared to be activated in response to GATA2 misexpression
(Fig. 5D,E). Thus, GATA2
appeared to be a strong inhibitor of Notch signalling, which raised the
possibility that it could function in concert with proneural activity. To
address this question specifically, we decided to analyse the consequences of
inhibiting proneural function in the Gata2 gain-of-function context.
To this end GATA2-HA was misexpressed with Id2, a bHLH regulatory protein that
has been shown to inhibit the function of proneural proteins. We then observed
that GATA2-HA was still able to induce Cash1
(Fig. 6A,B) activation and
chick Hes5 repression (Fig.
6C,D). Similarly, GATA2-induced neuronal differentiation was not
abolished by Id2, as assessed by ßIII-tubulin expression (data not
shown). The sole contrasting effect of Id2 co-expression was the activation of
Ngn2 (Fig. 6E,F). This
can be assigned to Id2 function as it was also observed in the presence of Id2
alone (Fig. 6G,J). By contrast,
Cash1 and Hes5 did not appear to be affected by Id2
misexpression (Fig. 6G-I).
These results established that: (1) proneural activity is not required for
GATA2 to extinguish Notch signalling and to induce Mash1 and neuronal
differentiation; and (2) Id2 appears to alleviate the repression of
Ngn2 transcription observed in the presence of GATA2 alone.
|
|
The marked difference in the proliferation rate between Gata2 wild-type and mutant ENC was probably due to a shortening of the division time in the absence of GATA2. In order to confirm this, BrdU incorporation was performed in two cultures representative of the wild-type and of the mutant ENC. Both cultures were driven into quiescence by serum deprivation for 24 hours. ENC were allowed to re-enter the cell cycle by addition of foetal calf serum and BrdU in the culture medium, and the rate of BrdU incorporation was compared at time intervals. As shown in Fig. 7G, the percentage of BrdU-positive ENC increased steadily in the mutant cells upon reentry into the cell cycle. By contrast, such an increase was clearly delayed in the wild-type ENC. Indeed, 60% of the mutant cells, but only 10% of the wild-type cells, were BrdU positive 8 hours after cell cycle reactivation. These results established that the time necessary to reach the G1/S phase was shorter in mutant ENC, thus implying a shortening of the G1 phase in the absence of GATA2. This prompted us to compare the status of cyclin D transcription in wild-type and mutant cells. By performing semi-quantitative RT-PCR, we found that the levels of cyclin D1 and cyclin D2 were higher in the wild-type than in the Gata2/ ENC, three- and fourfold respectively, whereas no significant differences were observed in the case of cyclin D3 and of p27 (Fig. 7H). In addition, the same approach demonstrated that the level of cyclin E1 transcripts was increased by threefold in Gata2 mutant ENC (Fig. 7H). The results concerning cyclin D1 and cyclin D2 were further confirmed by performing quantitative RT-PCR experiments that showed that the level of transcripts in mutant cells was decreased three- and fivefold, respectively, in comparison with wild-type cells. Consistent with the observations we made in vivo, the concentration of Notch1 transcripts in wild type ENC cells was found to be 4.5-fold lower than in Gata2-deficient ENC.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Gata2 is sufficient to inhibit cell proliferation but may require further instruction to induce neuronal differentiation
As estimated by BrdU incorporation, GATA2 expression can be sufficient to
impede the proliferation of neural progenitors, in vivo as in culture, in ENC
or NB2a cells. As visualised by p27, ßIII-tubulin, neurofilament and NeuN
expression, this effect can be further associated with cell cycle exit and
neuronal differentiation in vivo. However, if outsets of early neuronal
differentiation are primarily observed in GATA2-misexpressing cells in vivo,
it appears that part of these cells are not able to keep differentiating
properly and become negative for such markers 48 hours after electroporation.
Furthermore, no differentiation was observed in culture. Consistently, we
suggest that GATA2 may not be always sufficient to consolidate the
post-mitotic stage and enable cells to irremediably progress along the
differentiation pathway, which may require further molecular events obviously
absent in our culture conditions.
Gata2 interferes with the control of expression of components of the cell cycle machinery
To gain further insight into how GATA2 can eventually participate in cell
cycle withdrawal, we focused our studies on D-cyclins and Kip proteins, which
are known to play a crucial role during the G1 phase in committing the cells
towards either the G0 phase or, conversely, the G1/S transition. According to
our expression studies, a low level of activation of the D-cyclins may be
sufficient to enable them to participate in the maintenance of cell division,
whereas distinct upregulation features appear to be involved in other
functions. Indeed, previous reports have shown that high levels of D-cyclins,
which can result from either more active gene transcription or further
stabilisation of the transcripts, impede cell cycle progression and sustain
the maintenance of quiescence (Meyyappan
et al., 1998
; Pagano et al.,
1994
). Cyclin D2 transcription pattern is consistent with a
general function during the maturation phase of neurons, which could thus be
related to consolidation of the postmitotic stage. In addition, it can
eventually denote a more specific role, which remains to be understood, during
neuronal differentiation. By contrast, the region-specific aspect of cyclin D1
upregulation indicates that environmental cues are implicated in the
regulation of this cyclin gene, which is consistent with the fact that growth
factors and signalling pathways (Lobjois
et al., 2004
) have been shown to largely account for distinct
expression features of D-cyclins in the early neural plate
(Lobjois et al., 2004
;
Wianny et al., 1998
).
Downstream of signalling pathways, specification genes such as Gata2
may be implicated in the regulation of transcription activation. Further
analysis will be necessary to gain more insight into the eventual role of this
cyclin during the specification of neural progenitors. With regard to this, we
have shown that GATA2 is able to cause transient upregulation of cyclin D1 in
vivo and may thus participate in this upregulation in V2 precursors. The same
influence of GATA2 on cyclin D1 and D2 transcription has been established in
ENC cells. In the case of cyclin D2, this was in discrepancy with the fact
that the expression pattern of this cyclin did not seem to be altered in vivo
in Gata2 mutant embryos. This could possibly be explained in a number
of ways: (1) the distribution of cells expressing GATA2 at E10.5 and of
ventral cells exhibiting the higher level of cyclin D2 transcription
which might be too low to provide clear evidence of altered expression in
absence of GATA2; (2) compensatory mechanisms taking place in vivo, as
described in KO mice for D-cyclins (Kozar
et al., 2004
); and (3) the existence of a distinct regulatory
mechanism involving Gata2 and taking place only in culture. The
downregulation of cyclin E observed in ENC could be a consequence of the
higher expression of cyclin D1 and D2. Indeed, at high concentrations,
D-cyclins can inactivate CDK2 by disrupting the complex it forms with cyclin
E. This can result in the inhibition of events underlying the progression
towards the S phase, in particular the upregulation of cyclin E
(Meyyappan et al., 1998
;
Pagano et al., 1994
).
Once cells have been committed to leave the cell cycle, further events may
be required to consolidate the post-mitotic stage, such as the expression of
p27/Kip1 and/or p57/Kip2 proteins. In fact, p27 continuously delineates the
marginal zone, whereas p57/Kip2 is barely detected in the motoneuron and V2
domains. Although the functional consequences of such distinct regional
features have not yet been elucidated, they denote the potential existence of
different mechanisms underlying cell cycle withdrawal among neural progenitors
with respect to their position along the dorsoventral axis. Furthermore, the
fact that p27 transcripts were found to be widely distributed in the
neural tube supports the idea that the protein synthesis in the marginal layer
relies on post-transcriptional controls. Indeed, translational
(Kullmann et al., 2002
) and
post-translational (Tsvetkov et al.,
1999
; Zhang et al.,
2005
) events largely account for the control of p27/Kip1 protein
expression. Our gain- and loss-of-function analyses strongly support that
Gata2 can contribute to this control in vivo. Furthermore, the lack
of p27 protein occurring in GATA2-deficient precursors does not appear to be
compensated for by p57/Kip2, and this raises the issue of the alteration of
cell cycle exit in these precursors. The expected consequence of such a
situation could be increased proliferation. This was overtly manifested by ENC
in culture but was not observed in vivo. This failure might be due to the low
distribution of cells activating Gata2 in the ventral spinal cord at
E10.5, which was found to be even more restricted in Gata2 mutant
embryos. Considering that cell death could not explain it, this pronounced
restriction could be accounted for by two non-mutually exclusive hypotheses:
(1) a possible switch in cell fate and the subsequent downregulation of the
Gata2 locus; and (2) the lack of auto-activation potentially induced
by GATA2. The latter hypothesis is strongly supported by the fact that
exogenous GATA2 expression induced activation of the endogenous Gata2
and cyclin D1 genes in both a cell-autonomous and non-cell-autonomous manner.
Complementation experiments in Gata2/ ENC,
which confirmed the existence of this non-cell autonomous effect, suggest that
endogenous functional Gata2 is not necessary to mediate this effect,
which appears to function in absence of GATA2 and to be mediated by a secreted
factor not yet identified. This is also consistent with the hypothesis that
the transcription of cyclin D1 and D2 may not be directly regulated by GATA2.
It will be interesting to gain further insight into this transcriptional
control and into how this non-cell-autonomous mechanism is controlled in the
spinal cord so that Gata2 activation is restricted to V2
precursors.
Gata2 interferes with the Notch pathway
The Notch silencing caused by Gata2 gain-of-function manipulations
is consistent with the arrest of proliferation and the induction of neuronal
differentiation. This effect on the Notch pathway may occur in different ways.
First, Notch signalling involves an auto-regulatory loop, which means that
alteration of the expression of any component of the loop will alter the
expression of other components (Huppert et
al., 1997
) (for a review, see
Artavanis-Tsakonas et al.,
1999
). Second, Notch silencing may simply be a consequence of
negative regulation of the cell cycle by Gata2 as interference
between Notch signalling and cell cycle components has been reported
(Wai et al., 1999
). Finally,
we cannot rule out that it may rely on degradation processes that control
Notch turnover (Oberg et al.,
2001
; Schweisguth,
1999
). Although our data do not allow us to determine the way in
which Gata2 impedes Notch signalling, despite Cash1
activation, they support the idea that this functional aspect of
Gata2 does not require proneural activity. Indeed, in addition to its
proneural activity, Mash1/Cash1 is involved in neuron-type
specification. The two functional aspects have been described to be
mechanistically distinct (Parras et al.,
2002
; Pattyn et al.,
2004
), and we think that Cash1 activation by GATA2 is
associated with a function in neuronal specification
(Craven et al., 2004
;
Pattyn et al., 2004
) and not
with proneural activity.
In conclusion, our studies have revealed new aspects of the function of Gata2 during neurogenesis related to the control of the proliferation of neural progenitors. They provide further evidence of a possible crosstalk between proneural and specification genes that intervene during neuronal fate determination.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Supplementary material for this article is available at http://dev.biologists.org/cgi/content/full/133/11/2155/DC1
* These authors contributed equally to this work ![]()
Present address: UMR CNRS 7091 LGN, Bâtiment CERVI, CHU
Pitié-Salpêrière, 83 boulevard de l'Hôpital, 75013
Paris, France ![]()
| REFERENCES |
|---|
|
|
|---|
Artavanis-Tsakonas, S., Rand, M. D. and Lake, R. J.
(1999). Notch signaling: cell fate control and signal integration
in development. Science
284,770
-776.
Bertrand, N., Castro, D. S. and Guillemot, F. (2002). Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517-530.[CrossRef][Medline]
Blader, P., Fischer, N., Gradwohl, G., Guillemot, F. and Strahle, U. (1997). The activity of neurogenin1 is controlled by local cues in the zebrafish embryo. Development 124,4557 -4569.[Abstract]
Briscoe, J., Pierani, A., Jessell, T. M. and Ericson, J. (2000). A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 101,435 -445.[CrossRef][Medline]
Campos, L. S., Duarte, A. J., Branco, T. and Henrique, D. (2001). mDll1 and mDll3 expression in the developing mouse brain: role in the establishment of the early cortex. J. Neurosci. Res. 64,590 -598.[CrossRef][Medline]
Craven, S. E., Lim, K. C., Ye, W., Engel, J. D., de Sauvage, F.
and Rosenthal, A. (2004). Gata2 specifies serotonergic
neurons downstream of sonic hedgehog. Development
131,1165
-1173.
Cremisi, F., Philpott, A. and Ohnuma, S. (2003). Cell cycle and cell fate interactions in neural development. Curr. Opin. Neurobiol. 13, 26-33.[CrossRef][Medline]
Cunningham, J. J. and Roussel, M. F. (2001).
Cyclin-dependent kinase inhibitors in the development of the central nervous
system. Cell Growth Differ.
12,387
-396.
Dubreuil, V., Hirsch, M. R., Pattyn, A., Brunet, J. F. and Goridis, C. (2000). The Phox2b transcription factor coordinately regulates neuronal cell cycle exit and identity. Development 127,5191 -5201.[Abstract]
Dyer, M. A. and Cepko, C. L. (2001). p27Kip1
and p57Kip2 regulate proliferation in distinct retinal progenitor cell
populations. J. Neurosci.
21,4259
-4271.
Edlund, T. and Jessell, T. M. (1999). Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell 96,211 -224.[CrossRef][Medline]
Franco, P. G., Paganelli, A. R., Lopez, S. L. and Carrasco, A. E. (1999). Functional association of retinoic acid and hedgehog signaling in Xenopus primary neurogenesis. Development 126,4257 -4265.[Abstract]
Galderisi, U., Jori, F. P. and Giordano, A. (2003). Cell cycle regulation and neural differentiation. Oncogene 22,5208 -5219.[CrossRef][Medline]
Giudicelli, F., Taillebourg, E., Charnay, P. and
Gilardi-Hebenstreit, P. (2001). Krox-20 patterns the
hindbrain through both cell-autonomous and non cell-autonomous mechanisms.
Genes Dev. 15,567
-580.
Gradwohl, G., Fode, C. and Guillemot, F. (1996). Restricted expression of a novel murine atonal-related bHLH protein in undifferentiated neural precursors. Dev. Biol. 180,227 -241.[CrossRef][Medline]
Groves, A. K., George, K. M., Tissier-Seta, J. P., Engel, J. D., Brunet, J. F. and Anderson, D. J. (1995). Differential regulation of transcription factor gene expression and phenotypic markers in developing sympathetic neurons. Development 121,887 -901.[Abstract]
Hofmann, M., Schuster-Gossler, K., Watabe-Rudolph, M., Aulehla,
A., Herrmann, B. G. and Gossler, A. (2004). WNT signaling, in
synergy with T/TBX6, controls Notch signaling by regulating Dll1 expression in
the presomitic mesoderm of mouse embryos. Genes Dev.
18,2712
-2717.
Huppert, S. S., Jacobsen, T. L. and Muskavitch, M. A. (1997). Feedback regulation is central to Delta-Notch signalling required for Drosophila wing vein morphogenesis. Development 124,3283 -3291.[Abstract]
Karunaratne, A., Hargrave, M., Poh, A. and Yamada, T. (2002). GATA proteins identify a novel ventral interneuron subclass in the developing chick spinal cord. Dev. Biol. 249,30 -43.[CrossRef][Medline]
Kozar, K., Ciemerych, M. A., Rebel, V. I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Qunyan, Y. Q., Bhattacharya, S., Bronson, R. T. et al. (2004). Mouse development and cell proliferation in the absence of D-cyclins. Cell 118,477 -491.[CrossRef][Medline]
Kullmann, M., Gopfert, U., Siewe, B. and Hengst, L.
(2002). ELAV/Hu proteins inhibit p27 translation via an IRES
element in the p27 5'UTR. Genes Dev.
16,3087
-3099.
Lindsell, C. E., Boulter, J., diSibio, G., Gossler, A. and Weinmaster, G. (1996). Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol. Cell Neurosci. 8, 14-27.[CrossRef][Medline]
Livesey, F. J. and Cepko, C. L. (2001). Vertebrate neural cell-fate determination: lessons from the retina. Nat. Rev. Neurosci. 2,109 -118.[CrossRef][Medline]
Lobjois, V., Benazeraf, B., Bertrand, N., Medevielle, F. and Pituello, F. (2004). Specific regulation of cyclins D1 and D2 by FGF and Shh signaling coordinates cell cycle progression, patterning, and differentiation during early steps of spinal cord development. Dev. Biol. 273,195 -209.[CrossRef][Medline]
Meyyappan, M., Wong, H., Hull, C. and Riabowol, K. T.
(1998). Increased expression of cyclin D2 during multiple states
of growth arrest in primary and established cells. Mol. Cell.
Biol. 18,3163
-3172.
Murray, A. (2004). Recycling the cell cycle: cyclins revisited. Cell 116,221 -234.[CrossRef][Medline]
Nardelli, J., Thiesson, D., Fujiwara, Y., Tsai, F. Y. and Orkin, S. H. (1999). Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev. Biol. 210,305 -321.[CrossRef][Medline]
Nardelli, J., Catala, M. and Charnay, P. (2003). Establishment of embryonic neuroepithelial cell lines exhibiting an epiplastic expression pattern of region specific markers. J. Neurosci. Res. 73,737 -752.[CrossRef][Medline]
Novitch, B. G., Chen, A. I. and Jessell, T. M. (2001). Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31,773 -789.[CrossRef][Medline]
Oberg, C., Li, J., Pauley, A., Wolf, E., Gurney, M. and Lendahl,
U. (2001). The Notch intracellular domain is ubiquitinated
and negatively regulated by the mammalian Sel-10 homolog. J. Biol.
Chem. 276,35847
-35853.
Ohnuma, S. and Harris, W. A. (2003). Neurogenesis and the cell cycle. Neuron 40,199 -208.[CrossRef][Medline]
Ohnuma, S., Hopper, S., Wang, K. C., Philpott, A. and Harris, W. A. (2002). Co-ordinating retinal histogenesis: early cell cycle exit enhances early cell fate determination in the Xenopus retina. Development 129,2435 -2446.[Medline]
Pagano, M., Theodoras, A. M., Tam, S. W. and Draetta, G. F.
(1994). Cyclin D1-mediated inhibition of repair and replicative
DNA synthesis in human fibroblasts. Genes Dev.
8,1627
-1639.
Parras, C. M., Schuurmans, C., Scardigli, R., Kim, J., Anderson,
D. J. and Guillemot, F. (2002). Divergent functions of the
proneural genes Mash1 and Ngn2 in the specification of neuronal subtype
identity. Genes Dev. 16,324
-338.
Pata, I., Studer, M., van Doorninck, J. H., Briscoe, J., Kuuse, S., Engel, J. D., Grosveld, F. and Karis, A. (1999). The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4. Developmen